Irinotecan-containing doublet treatment versus irinotecan monotherapy as second-line choice for advanced gastric cancer

BACKGROUND: For patients with advanced gastric cancer (AGC), second-line chemotherapy regimen remains controversial. The efficacy and safety of irinotecan-containing doublet treatment and irinotecan monotherapy were compared in this systematic analysis. METHODS: A search was conducted on EMBASE and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMC Gastroenterol
Autores principales: Yang, Liuting, Jiang, Xiaoyue, Yan, Han, Li, Yingying, Zhen, Hongchao, Chang, Bingmei, Kariminia, Seyed, Li, Qin
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5879920/
https://ncbi.nlm.nih.gov/pubmed/29609559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-018-0772-4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares